Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
J Cardiothorac Vasc Anesth ; 19(5): 597-602, 2005 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-16202892

RESUMEN

OBJECTIVE: The purpose of this study was to compare the hemodynamic, hepatorenal, and postoperative effects of desflurane-fentanyl and midazolam-fentanyl anesthesia during coronary artery bypass surgery. DESIGN: Prospective study. SETTING: University hospital. PARTICIPANTS: Sixty patients undergoing elective coronary artery bypass grafting surgery with ejection fraction more than 45%. INTERVENTIONS: Anesthesia was induced with etomidate, 0.2 mg/kg, and fentanyl, 5 microg/kg, in group D (n = 30) and with midazolam, 0.1 to 0.3 mg/kg, and fentanyl, 5 microg/kg, in group M (n = 30). Anesthesia was maintained with desflurane, 2% to 6%, and fentanyl, 15 to 25 microg/kg, in group D and midazolam infusion, 0.1 to 0.5 mg/kg/h, and fentanyl, 15 to 25 microg/kg, in group M. MEASUREMENTS AND MAIN RESULTS: Hemodynamic monitoring included a 5-lead electrocardiogram, a radial artery catheter, and a pulmonary artery catheter. Data were obtained before induction of anesthesia (t0), after induction of anesthesia (t1), after intubation (t2), after surgical incision (t3), after sternotomy (t4), before cardiopulmonary bypass (t5), after protamine infusion (t6), and at the end of the surgery (t7). Blood samples were obtained to measure total bilirubin, aspartate aminotransferase, gamma glutamyl transferase, lactate dehydrogenase, alkaline phosphatase, creatinine, and blood urea nitrogen just before induction of anesthesia and at the first, fourth, and 14th days postoperatively. CONCLUSIONS: Intraoperative hemodynamic responses were similar in both groups, and transient hepatic and renal dysfunctions were observed in the postoperative period in both groups. The extubation and intensive care unit discharge times were found to be shorter in the desflurane-fentanyl group.


Asunto(s)
Anestésicos Combinados/uso terapéutico , Puente de Arteria Coronaria , Hemodinámica/efectos de los fármacos , Riñón/efectos de los fármacos , Hígado/efectos de los fármacos , Adulto , Anestésicos Combinados/administración & dosificación , Anestésicos Generales/administración & dosificación , Anestésicos Generales/uso terapéutico , Biomarcadores/metabolismo , Enfermedad Coronaria/fisiopatología , Enfermedad Coronaria/cirugía , Desflurano , Femenino , Fentanilo/administración & dosificación , Fentanilo/uso terapéutico , Humanos , Unidades de Cuidados Intensivos , Isoflurano/administración & dosificación , Isoflurano/análogos & derivados , Isoflurano/uso terapéutico , Riñón/metabolismo , Riñón/fisiología , Tiempo de Internación , Hígado/metabolismo , Hígado/fisiología , Masculino , Midazolam/administración & dosificación , Midazolam/uso terapéutico , Persona de Mediana Edad , Complicaciones Posoperatorias/etiología , Complicaciones Posoperatorias/metabolismo , Complicaciones Posoperatorias/fisiopatología , Estudios Prospectivos , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA